Filtered By:
Specialty: Universities & Medical Training
Condition: Thrombosis
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 257 results found since Jan 2013.
Cardiovascular Risk/Benefit Profile of MHT.
Conclusion: CV risk calculation should be considered by clinicians in order to exclude patients with high CV risk, in whom MHT is contraindicated. Assessing risks and benefits in a patient-centered approach according to individual's features, health status, and personal preferences is important in order to realize a safe and effective treatment.
PMID: 31500138 [PubMed - in process]
Source: Medicina (Kaunas) - September 5, 2019 Category: Universities & Medical Training Authors: Villa P, Amar ID, Shachor M, Cipolla C, Ingravalle F, Scambia G Tags: Medicina (Kaunas) Source Type: research
Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion.
Abstract
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke and thromboembolic complications. A rhythm control strategy with both electrical and pharmacological cardioversion is recommended for patients with symptomatic atrial fibrillation. Anticoagulant therapy for 3-4 weeks prior to cardioversion is recommended in order to avoid thromboembolic events deriving from restoring sinus rhythm. Transesophageal echocardiography has a pivotal role in this setting, excluding the presence of left atrial appendage thrombus before cardioversion. The aim of this review...
Source: Medicina (Kaunas) - August 20, 2019 Category: Universities & Medical Training Authors: Melillo E, Palmiero G, Ferro A, Mocavero PE, Monda V, Ascione L Tags: Medicina (Kaunas) Source Type: research
Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What's the Culprit?
Abstract
Stroke is a rare but possible complication after atrial fibrillation (AF) ablation. However, its etiopathogenesis is far from being completely characterized. Here we report a case of stroke, with recurrent peripheral embolism after AF ablation procedure. In our patient, an in situ femoral vein thrombosis and iatrogenic atrial septal defect were simultaneously detected. A comprehensive review of multiple pathophysiological mechanisms of stroke in this context is provided. The case underlines the importance of a global evaluation of patients undergoing AF ablation.
PMID: 31434315 [PubMed - in process]
Source: Medicina (Kaunas) - August 19, 2019 Category: Universities & Medical Training Authors: De Sensi F, Miracapillo G, Addonisio L, Breschi M, Cresti A, Baratta P, Paneni F, Limbruno U Tags: Medicina (Kaunas) Source Type: research
Association of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Treatment Modalities of Acute Ischaemic Stroke: A Pilot Study.
Conclusions: The main finding of this pilot study was that NLR in IS patients treated using thrombectomy following thrombolysis was markedly higher than that in other treatment groups, which was associated with increased severity of the disease in these patients. Therefore, patients with higher NLR may be expected to have more severe stroke. The link between stroke severity and NLR deserves further study.
PMID: 31284487 [PubMed - in process]
Source: Medicina (Kaunas) - July 4, 2019 Category: Universities & Medical Training Authors: Świtońska M, Słomka A, Korbal P, Piekuś-Słomka N, Sinkiewicz W, Sokal P, Żekanowska E Tags: Medicina (Kaunas) Source Type: research
New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report.
We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral anticoagulant, as she developed a major stroke involving the right carotid artery, due to deep venous thrombosis with pulmonary embolism. We therefore suggest a closer monitoring of the safety and efficacy of dabigatran. Moreover, in the presence of multifactorial causes of pro-coagulation, we believe that warfarin should remain the mainstay of oral anticoagulation.
PMID: 30884868 [PubMed - in process]
Source: Medicina (Kaunas) - March 16, 2019 Category: Universities & Medical Training Authors: Arcadi FA, Portaro S, Giorgianni R, Naro A, Casella C, Genovese C, Marino S, Calabrò RS Tags: Medicina (Kaunas) Source Type: research
Effects of Coronary Artery Revascularization with a Polymer-Free Biolimus A9-Coated BioFreedom Stent Versus Bypass Surgery before Noncardiac Surgery.
CONCLUSION: This study demonstrated that BioFreedom stenting as a revascularization strategy before major noncardiac surgery might be feasible and safe in selected patients with less severe coronary artery diseases.
PMID: 29749130 [PubMed - in process]
Source: Yonsei Medical Journal - May 13, 2018 Category: Universities & Medical Training Authors: Kim K, Kim C, Kim BK, Jang JY, Her AY, Kim S, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y Tags: Yonsei Med J Source Type: research
Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation
ConclusionsPatients with NVAF receiving rivaroxaban after RFCA procedures appear to benefit from a metabolic perspective compared with warfarin, providing practical clinical reference for the choice of the anticoagulant. Rivaroxaban seems to be as safe and effective in preventing thromboembolic events as warfarin for these patients.
Source: Journal of Zhejiang University. Science. B. - November 1, 2017 Category: Universities & Medical Training Source Type: research
Device used to close small hole in heart may protect against recurrent stroke
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial led by UCLA researchers.“It is a major new treatment option for some people,” said Dr. Jeffrey Saver, director of theUCLA Comprehensive Stroke Center and lead author of the study. However, he added, “Using the device is going to have to be a considered clinical decision between the doctor and the patient about who’s the right person to get it.”Thefindings appear in the Sept. 14 New England Jo...
Source: UCLA Newsroom: Health Sciences - September 14, 2017 Category: Universities & Medical Training Source Type: news
For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases
This study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggests that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause.AUTHORSThe paper ’s authors are Dr. Carolyn Crandall of UCLA; Kathleen Hovey of the State University of New York at Buffalo; Christopher Andrews of the University of Michigan; Dr. Rowan Chlebowski of City of Hope; Marcia Stefanick of Stanford University; Dr. Dorothy Lane of the State University of New York at Ston y Brook; Dr. Jan Shifre...
Source: UCLA Newsroom: Health Sciences - August 16, 2017 Category: Universities & Medical Training Source Type: news
Glutathione peroxidase 3 gene polymorphisms and the risk of sudden sensorineural hearing loss
Publication date: Available online 9 May 2017 Source:The Kaohsiung Journal of Medical Sciences Author(s): Chen-Yu Chien, Tzu-Yen Huang, Shu-Yu Tai, Ning-Chia Chang, Hsun-Mo Wang, Ling-Feng Wang, Kuen-Yao Ho The glutathione peroxidase 3 gene (GPX3) is reported to be a risk factor for arterial ischaemic stroke and cerebral venous thrombosis. GPX3 may be one of the aetiologies of sudden sensorineural hearing loss (SSNHL), which might be attributed to the genetic effect of GPX3 by influence reactive oxygen species (ROS). Unbalanced ROS have been associated with susceptibility to SSNHL. Therefore, we conducted a case–control...
Source: The Kaohsiung Journal of Medical Sciences - May 10, 2017 Category: Universities & Medical Training Source Type: research
Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching.
CONCLUSION: In this cohort of patients treated with BES or ZES, the rate of MACCEs at 1 year was low and significantly not different between both groups.
PMID: 28120558 [PubMed - in process]
Source: Yonsei Medical Journal - January 27, 2017 Category: Universities & Medical Training Authors: Tantawy A, Ahn CM, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK Tags: Yonsei Med J Source Type: research
Crucial role of carotid ultrasound for the rapid diagnosis of hyperacute aortic dissection complicated by cerebral infarction: A case report and literature review.
Abstract
Aortic dissection is a life-threatening rare condition that may virtually present by any organ system dysfunction, the nervous system included. Acute cerebral infarction among multiple other neurological and non-neurological presentations is part of this acute aortic syndrome. Rapid and correct diagnosis is of extreme importance keeping in mind the possibility of thrombolytic treatment if a patient with a suspected ischemic stroke arrives to the Emergency Department within a 4.5-h window after symptom onset. Systemic intravenous thrombolysis in the case of an acute brain infarction due to aortic dissectio...
Source: Medicina (Kaunas) - November 18, 2016 Category: Universities & Medical Training Authors: Sukockienė E, Laučkaitė K, Jankauskas A, Mickevičienė D, Jurkevičienė G, Vaitkus A, Stankevičius E, Petrikonis K, Rastenytė D Tags: Medicina (Kaunas) Source Type: research
Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
CONCLUSION: Pre-procedural anticoagulation duration was shorter and intra-procedural heparin requirement was higher with NOAC than with uninterrupted warfarin during AF ablation. Although the peri-procedural thromboembolism and bleeding incidences did not differ, minor stroke occurred in two cases in the NOAC group.
PMID: 26847285 [PubMed - in process]
Source: Yonsei Medical Journal - February 8, 2016 Category: Universities & Medical Training Authors: Shin DG, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Pak HN Tags: Yonsei Med J Source Type: research
CHADS2 versus CHA2DS2-VASc scoring systems for predicting left atrial thrombus in patients with nonvalvular atrial fibrillation.
CONCLUSION: The average score of CHA2DS2-VASc is higher than that of CHADS2 and has better predictive ability for left atrial thrombus.
PMID: 25413057 [PubMed - in process]
Source: Journal of Southern Medical University - November 20, 2014 Category: Universities & Medical Training Authors: Gu J, Jia FP, Feng PP Tags: Nan Fang Yi Ke Da Xue Xue Bao Source Type: research
The usefulness of the kurashiki prehospital stroke scale in identifying thrombolytic candidates in acute ischemic stroke.
Conclusion: The KPSS is an effective prehospital stroke scale for identifying candidates for IV-tPA and IA-UK, as indicated by excellent correlation with the NIHSS, in the assessment of stroke severity in acute ischemic stroke.
PMID: 24532511 [PubMed - in process]
Source: Yonsei Medical Journal - February 19, 2014 Category: Universities & Medical Training Authors: Jang J, Chung SP, Park I, You JS, Lee HS, Park JW, Chung TN, Chung HS, Lee HS Tags: Yonsei Med J Source Type: research
